Editorial of Special Column “Research on Emerging COVID-19 (Target, Mechanism, and Therapeutics)”
Hai-Bin Luo,
Shilin Chen,
Peiqing Liu
Affiliations
Hai-Bin Luo
School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China
Shilin Chen
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China
Peiqing Liu
Laboratory of Pharmacology & Toxicology and New Drug R&D Center, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China